Interestingly, a study has described how a mutation to the KRAS gene in pancreatic cancer cells display elevated levels of macropinocytosis, a form of endocytosis, of proteins such as albumin [130], a fact which may be behind the recent success of Abraxane in treating advanced pancreatic cancer [131]. The gene discussed is ALB; the disease is pancreatic neoplasm.